Role of endogenous pituitary adenylate cyclase activating polypeptide (PACAP) in myelination of the rodent brain: lessons from PACAP-deficient mice
- PMID: 21726625
- DOI: 10.1016/j.ijdevneu.2011.06.008
Role of endogenous pituitary adenylate cyclase activating polypeptide (PACAP) in myelination of the rodent brain: lessons from PACAP-deficient mice
Abstract
Pituitary adenylate-cyclase activator polypeptide (PACAP), as a consequence of its effect on the elevation of intracellular cAMP level, strongly influences brain development including myelination. While proliferation of oligodendroglial progenitors is stimulated by PACAP applied in vitro, their differentiation is inhibited. However, the in vivo role of PACAP on myelination has never been examined. In the present study the role of endogenous PACAP in myelination was examined in PACAP-deficient mice, in several areas of the brain with a special attention to the cerebral cortex. In young postnatal and adult mice myelination was studied with immunohistochemistry detecting a protein present in the myelin sheath, the myelin basic protein, with Luxol Fast Blue staining and with electron microscopy. Results obtained in PACAP-deficient mice were compared to age-matched wild type controls. We found that the sequence of myelination in the PACAP-deficient animals was similar to that observed in controls. According to this, in both PACAP-deficient and wild type mice, the somatosensory cortex was myelinated before motor areas that preceded the myelination of associational cortical areas. Archicortical associational areas such as the cingulate cortex were myelinated before neocortical areas. Myelination in the corpus callosum followed the known rostro-caudal direction in both PACAP-deficient and wild type animals, and the ventrolateral part of the corpus callosum was myelinated earlier than the dorsomedial part in both groups. In contrast to the similarity in its sequence, striking difference was found in the onset of myelination that started earlier in PACAP-deficient mice than in wild type controls in all of the examined brain regions, including cerebral archi- and neocortex. The first myelinated axons in each of the examined brain regions were observed earlier in the PACAP-deficient mice than in controls. When age-matched animals of the two groups were compared, density of myelinated fibers in the PACAP-deficient mice was higher than in controls in all of the examined areas. We propose that endogenous PACAP exerts an inhibitory role on myelination in vivo. Since myelin sheath of the central nervous system contains several factors blocking neurite outgrowth, inhibition of myelination by PACAP gives time for axonal development and synapse formation, and therefore, strengthens neuronal plasticity.
Copyright © 2011 ISDN. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
A correlative light and electron microscopic study of postnatal myelination in the murine corpus callosum.Int J Dev Neurosci. 2008 Oct;26(6):575-84. doi: 10.1016/j.ijdevneu.2008.05.003. Epub 2008 May 15. Int J Dev Neurosci. 2008. PMID: 18556167
-
Tissue-specific and developmental expression of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in rat brain.Eur J Neurosci. 1996 Feb;8(2):310-8. doi: 10.1111/j.1460-9568.1996.tb01215.x. Eur J Neurosci. 1996. PMID: 8714702
-
Impaired nocifensive behaviours and mechanical hyperalgesia, but enhanced thermal allodynia in pituitary adenylate cyclase-activating polypeptide deficient mice.Neuropeptides. 2010 Oct;44(5):363-71. doi: 10.1016/j.npep.2010.06.004. Neuropeptides. 2010. PMID: 20621353
-
Localization, characterization and function of pituitary adenylate cyclase-activating polypeptide during brain development.Peptides. 2007 Sep;28(9):1713-9. doi: 10.1016/j.peptides.2007.06.029. Epub 2007 Jul 14. Peptides. 2007. PMID: 17719696 Review.
-
[Pituitary adenylate cyclase-activating polypeptide].Ann Endocrinol (Paris). 1998 Dec;59(5):364-405. Ann Endocrinol (Paris). 1998. PMID: 9949891 Review. French.
Cited by
-
PACAP deficiency as a model of aging.Geroscience. 2018 Dec;40(5-6):437-452. doi: 10.1007/s11357-018-0045-8. Epub 2018 Oct 22. Geroscience. 2018. PMID: 30345481 Free PMC article. Review.
-
Neuroprotective Effects of gH625-lipoPACAP in an In Vitro Fluid Dynamic Model of Parkinson's Disease.Biomedicines. 2022 Oct 20;10(10):2644. doi: 10.3390/biomedicines10102644. Biomedicines. 2022. PMID: 36289905 Free PMC article.
-
PACAP is an endogenous protective factor-insights from PACAP-deficient mice.J Mol Neurosci. 2012 Nov;48(3):482-92. doi: 10.1007/s12031-012-9762-0. Epub 2012 Apr 14. J Mol Neurosci. 2012. PMID: 22528455
-
Differential Expression of PACAP/VIP Receptors in the Post-Mortem CNS White Matter of Multiple Sclerosis Donors.Int J Mol Sci. 2024 Aug 14;25(16):8850. doi: 10.3390/ijms25168850. Int J Mol Sci. 2024. PMID: 39201536 Free PMC article.
-
Pituitary adenylate cyclase activating polypeptide (PACAP) signalling exerts chondrogenesis promoting and protecting effects: implication of calcineurin as a downstream _target.PLoS One. 2014 Mar 18;9(3):e91541. doi: 10.1371/journal.pone.0091541. eCollection 2014. PLoS One. 2014. PMID: 24643018 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources